Lynda Polgreen
Physician · University of California
Credentials: · · ·
History
- Present
Pediatric Endocrinology
Pediatrics
Research
Diagnosis and Management of Osteopetrosis: Consensus Guidelines From the Osteopetrosis Working Group
Review · The Journal of Clinical Endocrinology & Metabolism · 2017 · Last of 12 authors · 173 citations
The Lancet · 2020 · 164 citations
Immunohematologic consequences of major ABO-mismatched bone marrow transplantation
Transplantation · 1988 · 119 citations
23 papers
- AP
16 papers
14 papers
11 papers
10 papers
8 papers
8 papers
- WM
8 papers
Grants
- 2010–2014
Natural History of Bone Disease and the Impact of Growth Hormone Treatment in MPS
National Institute of Arthritis and Musculoskeletal and Skin Diseases · K23
Contact PI · $533.7K · University of Minnesota
- 2009–2014
National Institute of Neurological Disorders and Stroke · U54
Project lead · $802.5K · University of Minnesota
- 2007–2009
GCRC-General Clinical Research Center
National Center for Research Resources · M01
Project lead · $16.5K · University of Minnesota
Clinical trials
- 2020–2023
Open-label Study of Anakinra in MPS III
Principal investigator · Completed · Phase 1, Phase 2
Lynda E Polgreen
- 2017–2027
Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI
Principal investigator · Active not recruiting · Phase 1, Phase 2
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- 2016–2019
ACTIMMUNE in Intermediate Osteopetrosis
Principal investigator · Completed · Phase 2
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- 2015–2016
Effects of Adalimumab in Mucopolysaccharidosis Types I, II and VI
Principal investigator · Completed · Phase 1, Phase 2
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center